Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Desferal
Deferoxamine is a chelating agent, specifically a siderophore, primarily used to treat acute iron poisoning and chronic iron overload due to conditions like thalassemia. It binds to free iron in the bloodstream, facilitating its excretion through the kidneys and preventing further iron-induced tissue damage. Deferoxamine is classified as a hydroxamic acid derivative.
For treatment of acute iron poisoning and chronic iron overload.
Outcome:
Increased risk of cardiac complications
Mechanism:
Synergistic cardiotoxicity
Outcome:
Increased aluminum absorption
Mechanism:
Chelation and enhanced absorption
Outcome:
Mild drowsiness
Mechanism:
Additive sedative effects
Most likely new formulation: Oral deferoxamine with enhanced absorption (Year 2026, 80% confidence)
Based on usage trends and ongoing research, there is a 70% likelihood of new deferoxamine formulations with improved bioavailability being approved within the next 5 years.
Chelating Agent, Iron Chelator
Hydroxamic Acid Derivative